Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$3.13
-0.015-0.48%
Last update: Sep 18, 2:30 PM
Prime Medicine Inc (PRME) Stock Price, Quote, News & History
PRMENASDAQ
Prime Medicine (PRME) Stock Price, Quote, News & History | Benzinga
Edge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Prime Medicine (PRME) stock?
You can purchase shares of Prime Medicine (NASDAQ:PRME) through any online brokerage.
Who are Prime Medicine (PRME) competitors?
Other companies in Prime Medicine’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
What is the forecast, or price target, for Prime Medicine (PRME) stock?
Prime Medicine has a consensus price target of $10.33.
What is the current price for Prime Medicine (PRME)?
The stock price for Prime Medicine (NASDAQ: PRME) is $3.125 last updated September 18, 2026 at 2:30 PM EDT.
Does Prime Medicine (PRME) pay a dividend?
There are no upcoming dividends for Prime Medicine.
When is Prime Medicine (NASDAQ:PRME) reporting earnings?
Prime Medicine does not have any upcoming earnings scheduled.
Is Prime Medicine (PRME) going to split?
There is no upcoming split for Prime Medicine.
What sector and industry does Prime Medicine (PRME) operate in?
Prime Medicine is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
